Navigation Links
Schering-Plough Reports Financial Results for 2009 First Quarter
Date:4/21/2009

ewer markets, adding new therapeutic areas, creating a leading global animal health business, and growing the consumer business through successful Rx-to-OTC switches;
  • Increasing the number of marketed products with sales above $1 billion from none in 2003 to five in 2008 (REMICADE, NASONEX and TEMODAR - as well as VYTORIN and ZETIA in the cholesterol joint venture);
  • Adding more than $12 billion to adjusted net sales, from $8.6 billion in 2003 to $20.8 billion in 2008;
  • Strengthening the company's financial position, going from negative free cash flow of nearly $1 billion in 2003 to generating positive free cash flow of more than $2 billion in 2008;
  • Successfully seeking, negotiating and integrating important and value-creating transactions, such as the acquisition of Organon BioSciences (OBS).

  • First Quarter 2009 Results

    For the 2009 first quarter, Schering-Plough reported net income available to common shareholders of $767 million or 46 cents per common share on a GAAP basis. Earnings per common share for the 2009 first quarter would have been 56 cents on earnings of $936 million on a reconciled basis, which excludes purchase accounting adjustments related to the OBS acquisition and special, merger and acquisition-related items. For the 2008 first quarter, Schering-Plough reported net income available to common shareholders of $276 million or 17 cents per common share on a GAAP basis and earnings of 53 cents per common share on a reconciled basis.

    GAAP net sales for the 2009 first quarter totaled $4.4 billion, down 6 percent as compared to the first quarter of 2008, reflecting 4 percent operational growth and an unfavorable impact from foreign exchange of 10 percent.

    Net sales of the cholesterol franchise, which include sales of the cholesterol joint venture plus sales recorded by Schering-Plough in
    '/>"/>

    SOURCE Schering-Plough Corporation
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

    Related medicine news :

    1. EPA Names Schering-Plough 2009 EPA ENERGY STAR(R) Partner of the Year
    2. Settlement Hearing on Schering-Plough Corporation Securities Litigation to be Held on June 1, 2009 at 2:00 P.M.
    3. Schering-Plough Withdraws From Barclays Capital Global Healthcare Conference
    4. Schering-Plough Declares Quarterly Dividends on Common Shares and Mandatory Convertible Preferred Stock
    5. Schering-Plough Completes Enrollment of Boceprevir Registration Studies in Treatment-Naive and Treatment-Experienced HCV Patients
    6. Schering-Plough Selects Benefit Advocates for Health Advocacy
    7. Schering-Plough Schedules Conference Call and Webcast for 2008 Fourth Quarter and Full Year Earnings
    8. Schering-Plough Announces European Submission of Fertility Medicine Corifollitropin Alfa
    9. Lupin Announces Litigation Settlement with Schering-Plough Corporation for Desloratadine(R)
    10. Schering-Plough Announces FDA Approval of PEGINTRON(TM) and REBETOL(R) Combination Therapy for Treating Pediatric Hepatitis C
    11. Schering-Plough to Webcast R&D Update Meeting
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/21/2014)... Mi (PRWEB) December 21, 2014 AlignLife ... child in need while at the same time helping people ... is a non-profit community-based organization committed to serving those persons ... meet their needs to improve the quality of life. Dr. ... make an impact in the local community and he knew ...
    (Date:12/21/2014)... 21, 2014 Parker & Sons, Inc. ... cooling, plumbing and other similar home contractor services announces ... regard to its expert contracting services. The company is ... has been serving Arizona for well over 40 years. ... absolute best in quality customer service to the residents ...
    (Date:12/21/2014)... (PRWEB) December 21, 2014 SCI ... of the issues and systemic barriers for disabled athletes ... Paratriathlon Champion. Scheidies has a condition called juvenile macular ... He describes how he adapted his athletic ambitions to ... his success in triathlon to pioneer the way for ...
    (Date:12/21/2014)... (PRWEB) December 21, 2014 As ... alleging heart attacks, stroke and blood clots from using ... increase, a new study shows that the male hormone ... cancer. In a study published in the Proceedings of ... James Amos-Landgraf examined a group of male rats with ...
    (Date:12/21/2014)... The Oncology Institute of Hope and Innovation hosted ... Whittier offices. The Hope for the Holidays Toy Drive is ... their families during the holiday season. This year, the toy ... between both offices. This event continues to be successful year ... team, store managers and assistant managers came out and not ...
    Breaking Medicine News(10 mins):Health News:AlignLife of Norton Shores Makes a Brighter Christmas for Kids in Muskegon 2Health News:Parker & Sons Announces Record Number Of Favorable Reviews In 2014 With Regard To Its Expert Contracting Services 2Health News:Parker & Sons Announces Record Number Of Favorable Reviews In 2014 With Regard To Its Expert Contracting Services 3Health News:Disability in Sports on SCI TV with Triathlon World Champ Aaron Scheidies 2Health News:Disability in Sports on SCI TV with Triathlon World Champ Aaron Scheidies 3Health News:New Low Testosterone Therapy Study Shows Male Hormone Testosterone May Contribute To Colon Cancer Reports Wright & Schulte LLC 2Health News:New Low Testosterone Therapy Study Shows Male Hormone Testosterone May Contribute To Colon Cancer Reports Wright & Schulte LLC 3Health News:New Low Testosterone Therapy Study Shows Male Hormone Testosterone May Contribute To Colon Cancer Reports Wright & Schulte LLC 4
    ... cancer patients who underwent a mastectomy who undergo ... reconstruction provides fewer long-term complications and better cosmetic ... to a study in the November issue of ... the official journal of the American Society for ...
    ... historic step toward a healthier, more equitable and affordable ... Council of Aging Organizations (LCAO) and the Consortium for ... of joint principles for reform. , ... over 150 organizations representing seniors, people with disabilities, and ...
    ... were infected last year , , THURSDAY, Nov. 20 (HealthDay ... routine HIV testing for Americans 13 to 64, such ... , This, despite the new testing guidelines and better ... suburban Washington D.C. The meeting was designed to review ...
    ... for Finding Quality Care , ARLINGTON HEIGHTS, Ill., ... economic downturn cannot afford to cut corners on quality of ... it,s one thing to temporarily substitute fillers for facelifts, ASPS ... price before professional training. This concern was discussed recently at ...
    ... Want to lower your risk for type,2 diabetes and heart disease? ... called the Diabetes Prevention Program showed that,dropping even just 5 to ... 2 diabetes. For a 180-pound person, 5 percent is just 9,pounds. ... today, one in five people have diabetes, and heart,disease is the ...
    ... of California, San Diego Health Sciences leaders have ... of Understanding (MOU) with Johnson & Johnson Pharmaceutical ... of developing future collaborations in biomedical research and ... MOU establishes a framework for future research and ...
    Cached Medicine News:Health News:Type of breast reconstruction impacts radiation therapy outcomes 2Health News:National Senior and Disability Advocates Agree on Principles for Financing Long-Term Services and Supports 2Health News:National Senior and Disability Advocates Agree on Principles for Financing Long-Term Services and Supports 3Health News:National Senior and Disability Advocates Agree on Principles for Financing Long-Term Services and Supports 4Health News:U.S. Lags on HIV Testing Goals 2Health News:U.S. Lags on HIV Testing Goals 3Health News:Caution Urged as Patients Seek Deals on Cosmetic Surgery 2Health News:The 5-Percent Plan: Preventing Diabetes and Heart Disease 2Health News:UC San Diego announces collaboration with Johnson & Johnson Pharmaceutical Research & Development 2
    (Date:12/19/2014)... Fla. , Dec. 19, 2014 Breckenridge ... a multi-product agreement with MSN Laboratories Pvt. Ltd. ( ... MSN expect to commercialize several new ANDAs.  Under the ... supply the products exclusively to Breckenridge for the U.S. ... under its label.  Breckenridge and MSN have agreed to ...
    (Date:12/19/2014)... CARDIFF-BY-THE-SEA, Calif. , Dec. 19, 2014 ... ;  Sorrento), an oncology company developing new treatments ... a privately-held immuno-oncology company developing proprietary Neukoplast ® ... therapy, announced today that the companies have entered ... generation CAR-TNK™ (pronounced as "Car-Tank") immunotherapies for the ...
    (Date:12/19/2014)... BURLINGTON, Mass. , Dec. 18, 2014  Decision ... the United States will increase ... Growth will be primarily driven by expansion in the ... direct energy devices will be increasingly adopted due to ... launched. Other key findings from Decision Resources ...
    Breaking Medicine Technology:Breckenridge Pharmaceutical signs Multi-Product Generic Agreement with MSN Laboratories Pvt. Ltd. 2Sorrento and Conkwest Announce Exclusive Global Collaboration 2Sorrento and Conkwest Announce Exclusive Global Collaboration 3Sorrento and Conkwest Announce Exclusive Global Collaboration 4Sorrento and Conkwest Announce Exclusive Global Collaboration 5U.S. Laparoscopic Device Market Will Reach Over $4.3 Billion by 2023 2U.S. Laparoscopic Device Market Will Reach Over $4.3 Billion by 2023 3
    ... 10, 2012 Cyberonics, Inc. (NASDAQ: CYBX ), ... management of epilepsy, today announced it will participate in the ... 2012, in New York. Greg Browne, Senior Vice ... Eastern Time.  A live audio webcast of the presentation can ...
    ... Feb. 10, 2012  Zacks highlights commentary from People and Picks ... http://photos.prnewswire.com/prnh/20101027/ZIRLOGO ) For more Voice of the People, ... Market Percolates, Doubters Wait They,re coming ... course the troll community. They,re telling you the market is ...
    Cached Medicine Technology:Zacks' Voice of the People highlights opportunities with Walgreen, Occidental Petroleum and Brown & Brown 2Zacks' Voice of the People highlights opportunities with Walgreen, Occidental Petroleum and Brown & Brown 3
    ... mg/kg sulfate (SO 4 ) ≤ 1000 mg/kg Cation ... Co ≤ 5 mg/kg Cr ≤ 10 mg/kg Cu ... 5 mg/kg Mg ≤ 5 mg/kg Mn ≤ 5 ... Pb ≤ 5 mg/kg Zn ≤ 5 mg/kg Special ...
    Application: Capable of separating DNA fragments of 50 to 1000 bp on a 3% gel Solubility: water 15 mg/mL, clear, colorless, hot Special grade: for molecular biology Suitab tst: electrophoresis te...
    Inquire...
    Inquire...
    Medicine Products: